BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20175229)

  • 1. [Nrf2 down-regulated cell line H460-N5 with Keap1 over-expression increased sensitivity to anti-cancer drugs].
    Qu LY; Gao P; Wang HY; Wang XJ; Tang XW
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 39(1):6-10. PubMed ID: 20175229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Down-regulation of Nrf2 enhances the cytotoxicity of Oxaliplatin to H460 cells].
    Xin A; Ren HY; Tang XW
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 39(1):11-6. PubMed ID: 20175230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory role of KEAP1 and NRF2 in PPARĪ³ expression and chemoresistance in human non-small-cell lung carcinoma cells.
    Zhan L; Zhang H; Zhang Q; Woods CG; Chen Y; Xue P; Dong J; Tokar EJ; Xu Y; Hou Y; Fu J; Yarborough K; Wang A; Qu W; Waalkes MP; Andersen ME; Pi J
    Free Radic Biol Med; 2012 Aug; 53(4):758-68. PubMed ID: 22684020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
    Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overexpression of Keap1 inhibits the cell proliferation and metastasis and overcomes the drug resistance in human lung cancer A549 cells].
    Weng X; Yan YY; Tong YH; Fan Y; Zeng JM; Wang LL; Lin NM
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):404-10. PubMed ID: 27346396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
    Wang XJ; Li Y; Luo L; Wang H; Chi Z; Xin A; Li X; Wu J; Tang X
    Free Radic Biol Med; 2014 May; 70():68-77. PubMed ID: 24556415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies.
    Hu L; Miao W; Loignon M; Kandouz M; Batist G
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):467-74. PubMed ID: 19940992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.
    Solis LM; Behrens C; Dong W; Suraokar M; Ozburn NC; Moran CA; Corvalan AH; Biswal S; Swisher SG; Bekele BN; Minna JD; Stewart DJ; Wistuba II
    Clin Cancer Res; 2010 Jul; 16(14):3743-53. PubMed ID: 20534738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.
    Konstantinopoulos PA; Spentzos D; Fountzilas E; Francoeur N; Sanisetty S; Grammatikos AP; Hecht JL; Cannistra SA
    Cancer Res; 2011 Aug; 71(15):5081-9. PubMed ID: 21676886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
    Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
    Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant sulforaphane and sensitizer trinitrobenzene sulfonate induce carboxylesterase-1 through a novel element transactivated by nuclear factor-E2 related factor-2.
    Chen YT; Shi D; Yang D; Yan B
    Biochem Pharmacol; 2012 Sep; 84(6):864-71. PubMed ID: 22776248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
    Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
    Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.
    Korenori Y; Tanigawa S; Kumamoto T; Qin S; Daikoku Y; Miyamori K; Nagai M; Hou DX
    Mol Nutr Food Res; 2013 May; 57(5):854-64. PubMed ID: 23390006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
    Khatri R; Shah P; Guha R; Rassool FV; Tomkinson AE; Brodie A; Jaiswal AK
    Mol Cancer Ther; 2015 Jul; 14(7):1728-37. PubMed ID: 25976679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells.
    Li CQ; Kim MY; Godoy LC; Thiantanawat A; Trudel LJ; Wogan GN
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14547-51. PubMed ID: 19706542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
    Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
    J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.